Developer docs
API playgroundTry for free, no card

Search company profiles

Dali Medical Devices

Full company profile

uuid002mvsj

Namestring
Dali Medical Devices
Legal namestring
DALI Medical Devices Ltd.
Websiteurl
dalimed.com
Company typeenum
Private
Founded yearint
2003
Descriptiontext

Dali Medical Devices Ltd. ("DALI") is a privately held Israeli medical-device company founded in 2003 and headquartered in Yavne. It designs, develops, and licenses disposable injectable drug-delivery devices — principally safety needles, auto-injectors, and a connected IoT syringe — for pharmaceutical, biosimilar, and biotech partners that need differentiated, patient-friendly delivery systems for self-administered chronic-disease therapies.

Its core technology falls into three product lines. The SAN family (SAN-L, SAN-Light, SAN-P, SAN-DV, SAN-DV Pro) provides automatic needle insertion, hidden-needle design, and passive sharps protection while letting patients control injection speed manually. The Flexi-Q auto-injector family (PFS, DV, mMU, EAI, HV) is developed in collaboration with E3D/Elcam Medical, which owns and commercializes the platform; Flexi-Q DV is FDA 510(k) cleared and Flexi-Q PFS has a US Device Master File. The SYNNECT connected digital syringe adds IoT/BLE connectivity, administration alerts, and cloud data transmission for remote patient monitoring. DALI holds multiple granted patents across the US, EU, and Israel protecting these mechanisms, and operates an ISO 13485-certified quality system.

DALI monetizes through B2B device licensing, customization, and contract development services for pharma and medical-device companies. Pricing is quote-based and not publicly disclosed. Distribution for auto-injectors is via partner E3D/Elcam Medical, while safety needles and SYNNECT are sold direct under licensing arrangements. The company targets pharma customers seeking lifecycle management and adherence benefits, with one disclosed commercial launch to date (SAN-Light customized for ADVANZ PHARMA's lanreotide product, CE marked October 2023). Co-founders David Daily (CEO) and Lior Raday (CTO) also spun out Everads Therapy in 2017 to pursue ophthalmic suprachoroidal injection technology.

Short descriptiontext

Dali Medical Devices is an Israeli private medical-device company that designs and licenses disposable safety needles, auto-injectors, and a connected IoT syringe to pharmaceutical and biotech partners for self-administered drug delivery and patient-compliance applications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersYavne, Israel
HQ citystring
Yavne
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
injectable drug delivery devices, disposable auto-injectors, safety needle systems, connected digital syringes, medical device development
Industry4 codes
PRIMARYHLAHAIAB
Auto-Injectors (Disposable & Reusable)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
SECONDARYHLAHAIAM
Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
SECONDARYHLAHAIAA
Prefilled Syringes & Safety Syringes
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
SECONDARYHLACAFAL
Connected Therapeutics & Smart Drug Delivery Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
NAICS code4 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Drug Delivery Devices
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Device Manufacturing and Licensing
TypeOne Time License
Description

DALI manufactures and licenses injectable drug delivery devices to pharmaceutical companies. Devices are offered as market-ready products or customized per specific pharmaceutical partner requirements. Auto-injectors are assigned/licensed to Elcam Medical while DALI maintains development and co-development partnerships.

dalimed.com
2Custom Development Services
TypeProfessional Services
Description

DALI provides contract development services from concept to commercialization, including design, verification and validation testing, regulatory support through relevant standards and regulations.

dalimed.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1SAN (Safe Auto Needle) Product Family
Description

A variety of injecting devices designed for Sharps Injury Prevention (SIP) and Safety Engineered Devices (SED), enabling safe and easy self-injection experience.

dalimed.com
+2 more records
Core offering1 text field

DALI Medical Devices develops, manufactures, and licenses injectable drug delivery devices for pharmaceutical partners, including the SAN family of automatic safety needles, the SYNNECT connected IoT digital syringe, and the Flexi-Q family of disposable auto-injectors. The company provides end-to-end services from concept and design through verification, validation, regulatory support, and commercialization, offering both market-ready products and customized devices tailored to specific drug delivery requirements.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Reduced local skin reactions through injection that starts only after full needle penetration
+2 more records
Product overview1 text field

DALI Medical Devices offers a comprehensive portfolio of injectable drug delivery devices organized into three main product lines: SAN (Safe Auto Needle) family for automatic safety needles and syringes, SYNNECT for connected digital syringes with IoT capabilities, and Flexi-Q family for auto-injectors. The SAN products include SAN-L for luer syringes, SAN-Light passive safety needle, SAN-P for prefilled syringes, and SAN-DV/DV Pro for drugs in vials. The SYNNECT connected syringe adds digital health features including injection monitoring and cloud connectivity. The Flexi-Q auto-injector family covers prefilled syringes (PFS), drugs in vials (DV), multi-dose use (mMU), emergency auto-injectors (EAI), and high-viscosity drugs (HV). The company partners with E3D (Elcam Drug Delivery Devices) for auto-injector development and commercialization.

Product and service11 records
1SAN-L
CategoryAutomatic Safety Needles
Description

Single-use sterile automatic safety needle for any type of luer syringe, combining automatic needle insertion, passive sharps protection, and hidden needle while allowing manual control of injection speed. Designed for pharmaceutical partners and self-injecting patients.

2SAN-Light
CategoryAutomatic Safety Needles
Description

Single-use sterile passive safety needle for any type of luer syringe, combining automatic needle shielding and hidden needle design for healthcare professionals and self-injecting patients.

3SAN-P
CategoryAutomatic Safety Needles
Description

Disposable self-injection solution for staked-needle prefilled syringes combining automatic needle insertion, passive sharps protection, and hidden needle with manual injection speed control.

4SAN-DV
CategoryAutomatic Safety Needles
Description

Fully disposable automatic needle with vial adaptor for use with drugs in vials, reducing patient anxiety and allowing control of injection speed.

5SAN-DV Pro
CategoryAutomatic Safety Needles
Description

Fully disposable automatic needle with integrated vial adaptor for easy drug reconstitution and mixing, designed for use with drugs in vials with automatic needle insertion and hidden needle.

6SYNNECT
CategoryConnected Digital Syringes
Description

Connected IoT syringe that adds sensing and connectivity technologies to regular syringes, monitoring injection process, providing administration alerts, and transmitting data via BLE to cloud for remote patient monitoring in clinical trials and marketed drugs.

7Flexi-Q PFS
CategoryAuto-Injectors
Description

Fully disposable auto-injector for prefilled syringes with passive needle shielding, designed to encourage patient compliance in self-injection.

8Flexi-Q DV
CategoryAuto-Injectors
Description

FDA 510(k) cleared fully disposable auto-injector for drugs in vials (lyophilized and liquid forms), providing unique user-friendly self-administration solution with simplified reconstitution and safe needle shielding.

9Flexi-Q mMU
CategoryAuto-Injectors
Description

Auto-injector with reusable driving unit and disposable cassette for prefilled syringes and vials, designed for chronic diseases requiring frequent injections with reduced cost per injection.

10Flexi-Q EAI
CategoryAuto-Injectors
Description

2-step fully disposable auto-injector for 1 mL or 2.25 mL pre-filled syringes with passive needle shielding for subcutaneous and intramuscular injection.

11Flexi-Q HV
CategoryAuto-Injectors
Description

Fully disposable auto-injector for low to high viscosity liquid drugs in prefilled syringes with proprietary damping mechanism, flexible delivery volumes of 0.1–1.0 mL.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2017-01-01
Description

In 2017, DALI co-founded Everads Therapy together with co-founders David and Lior, the Rad-Biomed incubator, and Sheba Tel Hashomer (City of Health). Everads Therapy is an Israeli startup developing a novel system for effective suprachoroidal injection based on invention by Dr. Ygal Rotenstreich. Everads represents DALI's spin-off company.

Strategic tierSupportingTypeStrategic or Co-development PartnerAnnounced on2017-01-01
Description

Co-investor in Everads Therapy spin-off company established in 2017 along with DALI co-founders and Sheba Tel Hashomer.

Strategic tierSupportingTypeStrategic or Co-development PartnerAnnounced on2017-01-01
Description

Medical center partner in co-founding Everads Therapy. Dr. Ygal Rotenstreich's invention for suprachoroidal injection forms the basis of Everads' novel injection system.

4E3D (Elcam Drug Delivery Devices)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

DALI has a licensing and contract development agreement with E3D, Elcam Drug Delivery Devices (sister company of Elcam Medical), covering a variety of auto-injectors for self-administration. DALI invents and develops the injectors in collaboration with Elcam. The FDA 510(k) clearance of the Flexi-Q DV auto-injector resulted from this long, stable, and mutually beneficial partnership spanning over 15 years.

dalimed.com
Strategic tierMajorTypeOEM/ Whitelabel/ Licensing Partner
Description

A customized version of DALI's SAN-Light passive safety needle was CE marked and launched by ADVANZ PHARMA for lanreotide (MYTOLAC/MYRELEZ) drug product. This represents a successful product launch with a pharmaceutical partner.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Swiss manufacturer of disposable auto-injectors (YpsoMate) and pen injectors serving global pharma and biotech customers. Directly competes with DALI's Flexi-Q family in the disposable auto-injector category with similar customization and licensing models.

TypeBroad incumbent
Description

German specialty glass and plastics manufacturer producing syringes, auto-injectors, and drug delivery devices. Provides comparable prefilled syringe and auto-injector solutions to pharma customers, overlapping with DALI's Flexi-Q and SAN portfolios.

TypeDirect peer
Description

Leading developer and manufacturer of advanced drug delivery systems including Molly, Maggie, and DAI auto-injectors. Directly competes with DALI's Flexi-Q family across disposable auto-injector formats serving biologic and biosimilar pharma partners.

TypeBroad incumbent
Description

Italian drug containment and delivery solutions provider offering syringes, vials, and auto-injector platforms. Now encompasses the Haselmeier auto-injector business, directly competing with DALI's Flexi-Q family across disposable and reusable auto-injector formats.

TypeDirect peer
Description

Israeli medical device company and DALI's long-standing strategic partner through its E3D subsidiary. Both companies are direct peers in disposable auto-injector development, with Elcam owning/commercializing the Flexi-Q family that DALI invented.

TypeEmerging player
Description

US-based developer of large-volume wearable injectors (enFuse) for subcutaneous delivery of high-volume biologics. Operates in an adjacent but expanding category that could compete with or complement DALI's Flexi-Q HV high-viscosity disposable platform.

TypeBroad incumbent
Description

Global leader in primary packaging and drug delivery devices including auto-injectors, prefilled syringes, and connected platforms (e.g., SmartDose). Directly comparable to DALI in serving pharma customers with injectable device platforms, but at significantly larger scale.

TypeBroad incumbent
Description

Global medical technology company with a substantial Pharmaceutical Systems segment offering prefilled syringes, auto-injectors, and safety systems. Broad incumbent competing with DALI across multiple product categories with greater scale and global reach.

TypeEmerging player
Description

US-based developer of innovative injectable drug delivery systems including the Credence Connect auto-injector with companion app for adherence monitoring. Directly comparable to DALI's SYNNECT connected syringe strategy, with overlapping focus on connected/compliance-enhancing delivery.

TypeDirect peer
Description

UK-based manufacturer of auto-injectors (Aidaptus), safety syringes, and pre-filled syringe platforms for global pharma. Directly comparable to DALI's SAN safety needle and Flexi-Q auto-injector families targeting self-injection and life-cycle management use cases.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Dali Medical Devices

Drug Delivery Devicesdalimed.com

Dali Medical Devices is an Israeli private medical-device company that designs and licenses disposable safety needles, auto-injectors, and a connected IoT syringe to pharmaceutical and biotech partners for self-administered drug delivery and patient-compliance applications.

What Dali Medical Devices does

Dali Medical Devices Ltd. ("DALI") is a privately held Israeli medical-device company founded in 2003 and headquartered in Yavne. It designs, develops, and licenses disposable injectable drug-delivery devices — principally safety needles, auto-injectors, and a connected IoT syringe — for pharmaceutical, biosimilar, and biotech partners that need differentiated, patient-friendly delivery systems for self-administered chronic-disease therapies.

Its core technology falls into three product lines. The SAN family (SAN-L, SAN-Light, SAN-P, SAN-DV, SAN-DV Pro) provides automatic needle insertion, hidden-needle design, and passive sharps protection while letting patients control injection speed manually. The Flexi-Q auto-injector family (PFS, DV, mMU, EAI, HV) is developed in collaboration with E3D/Elcam Medical, which owns and commercializes the platform; Flexi-Q DV is FDA 510(k) cleared and Flexi-Q PFS has a US Device Master File. The SYNNECT connected digital syringe adds IoT/BLE connectivity, administration alerts, and cloud data transmission for remote patient monitoring. DALI holds multiple granted patents across the US, EU, and Israel protecting these mechanisms, and operates an ISO 13485-certified quality system.

DALI monetizes through B2B device licensing, customization, and contract development services for pharma and medical-device companies. Pricing is quote-based and not publicly disclosed. Distribution for auto-injectors is via partner E3D/Elcam Medical, while safety needles and SYNNECT are sold direct under licensing arrangements. The company targets pharma customers seeking lifecycle management and adherence benefits, with one disclosed commercial launch to date (SAN-Light customized for ADVANZ PHARMA's lanreotide product, CE marked October 2023). Co-founders David Daily (CEO) and Lior Raday (CTO) also spun out Everads Therapy in 2017 to pursue ophthalmic suprachoroidal injection technology.

Dali Medical Devices firmographics

Firmographics
Name
Dali Medical Devices
Legal name
DALI Medical Devices Ltd.
Website
https://dalimed.com
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
11–50 employees
Short description
Dali Medical Devices is an Israeli private medical-device company that designs and licenses disposable safety needles, auto-injectors, and a connected IoT syringe to pharmaceutical and biotech partners for self-administered drug delivery and patient-compliance applications.
Ownership category
akta.pro rank

Dali Medical Devices industry classification

Industry
Product category
Drug Delivery Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHAIAB
Auto-Injectors (Disposable & Reusable)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
SECONDARYHLAHAIAM
Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
SECONDARYHLAHAIAA
Prefilled Syringes & Safety Syringes
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
SECONDARYHLACAFAL
Connected Therapeutics & Smart Drug Delivery Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

Keywords

  • Injectable drug delivery devices
  • Disposable auto-injectors
  • Safety needle systems
  • Connected digital syringes
  • Medical device development

Where Dali Medical Devices is headquartered

Location

Headquarters

HQ city
Yavne
HQ country
Israel
HQ region
Middle East

Offices1 record

Markets served

Dali Medical Devices business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Device Manufacturing and Licensing: DALI manufactures and licenses injectable drug delivery devices to pharmaceutical companies. Devices are offered as market-ready products or customized per specific pharmaceutical partner requirements. Auto-injectors are assigned/licensed to Elcam Medical while DALI maintains development and co-development partnerships.
  2. Custom Development Services: DALI provides contract development services from concept to commercialization, including design, verification and validation testing, regulatory support through relevant standards and regulations.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Dali Medical Devices product offering

Product offering

Core offering

DALI Medical Devices develops, manufactures, and licenses injectable drug delivery devices for pharmaceutical partners, including the SAN family of automatic safety needles, the SYNNECT connected IoT digital syringe, and the Flexi-Q family of disposable auto-injectors. The company provides end-to-end services from concept and design through verification, validation, regulatory support, and commercialization, offering both market-ready products and customized devices tailored to specific drug delivery requirements.

Product overview

DALI Medical Devices offers a comprehensive portfolio of injectable drug delivery devices organized into three main product lines: SAN (Safe Auto Needle) family for automatic safety needles and syringes, SYNNECT for connected digital syringes with IoT capabilities, and Flexi-Q family for auto-injectors. The SAN products include SAN-L for luer syringes, SAN-Light passive safety needle, SAN-P for prefilled syringes, and SAN-DV/DV Pro for drugs in vials. The SYNNECT connected syringe adds digital health features including injection monitoring and cloud connectivity. The Flexi-Q auto-injector family covers prefilled syringes (PFS), drugs in vials (DV), multi-dose use (mMU), emergency auto-injectors (EAI), and high-viscosity drugs (HV). The company partners with E3D (Elcam Drug Delivery Devices) for auto-injector development and commercialization.

Differentiator

Problem solved

Functional benefit

Brands

  • SAN (Safe Auto Needle) Product Family: A variety of injecting devices designed for Sharps Injury Prevention (SIP) and Safety Engineered Devices (SED), enabling safe and easy self-injection experience.
  • Flexi-Q Auto-Injector Family
  • SYNNECT

Products and services

  • SAN-L Single-use sterile automatic safety needle for any type of luer syringe, combining automatic needle insertion, passive sharps protection, and hidden needle while allowing manual control of injection speed. Designed for pharmaceutical partners and self-injecting patients.
  • SAN-Light Single-use sterile passive safety needle for any type of luer syringe, combining automatic needle shielding and hidden needle design for healthcare professionals and self-injecting patients.
  • SAN-P Disposable self-injection solution for staked-needle prefilled syringes combining automatic needle insertion, passive sharps protection, and hidden needle with manual injection speed control.
  • SAN-DV Fully disposable automatic needle with vial adaptor for use with drugs in vials, reducing patient anxiety and allowing control of injection speed.
  • SAN-DV Pro Fully disposable automatic needle with integrated vial adaptor for easy drug reconstitution and mixing, designed for use with drugs in vials with automatic needle insertion and hidden needle.
  • SYNNECT Connected IoT syringe that adds sensing and connectivity technologies to regular syringes, monitoring injection process, providing administration alerts, and transmitting data via BLE to cloud for remote patient monitoring in clinical trials and marketed drugs.
  • Flexi-Q PFS Fully disposable auto-injector for prefilled syringes with passive needle shielding, designed to encourage patient compliance in self-injection.
  • Flexi-Q DV FDA 510(k) cleared fully disposable auto-injector for drugs in vials (lyophilized and liquid forms), providing unique user-friendly self-administration solution with simplified reconstitution and safe needle shielding.
  • Flexi-Q mMU Auto-injector with reusable driving unit and disposable cassette for prefilled syringes and vials, designed for chronic diseases requiring frequent injections with reduced cost per injection.
  • Flexi-Q EAI 2-step fully disposable auto-injector for 1 mL or 2.25 mL pre-filled syringes with passive needle shielding for subcutaneous and intramuscular injection.
  • Flexi-Q HV Fully disposable auto-injector for low to high viscosity liquid drugs in prefilled syringes with proprietary damping mechanism, flexible delivery volumes of 0.1–1.0 mL.

Quantifiable outcome

  • Reduced local skin reactions through injection that starts only after full needle penetration
  • +2 more outcomes

Companies that use Dali Medical Devices

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Dali Medical Devices technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Dali Medical Devices partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core, supporting and major.

  • Everads TherapycoreStrategic or Co-development Partner · 1 January 2017In 2017, DALI co-founded Everads Therapy together with co-founders David and Lior, the Rad-Biomed incubator, and Sheba Tel Hashomer (City of Health). Everads Therapy is an Israeli startup developing a novel system for effective suprachoroidal injection based on invention by Dr. Ygal Rotenstreich. Everads represents DALI's spin-off company.
  • Rad-Biomed IncubatorsupportingStrategic or Co-development Partner · 1 January 2017Co-investor in Everads Therapy spin-off company established in 2017 along with DALI co-founders and Sheba Tel Hashomer.
  • Sheba Tel Hashomer (City of Health)supportingStrategic or Co-development Partner · 1 January 2017Medical center partner in co-founding Everads Therapy. Dr. Ygal Rotenstreich's invention for suprachoroidal injection forms the basis of Everads' novel injection system.
  • E3D (Elcam Drug Delivery Devices)coreStrategic or Co-development PartnerDALI has a licensing and contract development agreement with E3D, Elcam Drug Delivery Devices (sister company of Elcam Medical), covering a variety of auto-injectors for self-administration. DALI invents and develops the injectors in collaboration with Elcam. The FDA 510(k) clearance of the Flexi-Q DV auto-injector resulted from this long, stable, and mutually beneficial partnership spanning over 15 years.
  • ADVANZ PHARMAmajorOEM/ Whitelabel/ Licensing PartnerA customized version of DALI's SAN-Light passive safety needle was CE marked and launched by ADVANZ PHARMA for lanreotide (MYTOLAC/MYRELEZ) drug product. This represents a successful product launch with a pharmaceutical partner.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Dali Medical Devices competitors and assessment

Company assessment

Direct peers

  • Ypsomed Holding AG: Swiss manufacturer of disposable auto-injectors (YpsoMate) and pen injectors serving global pharma and biotech customers. Directly competes with DALI's Flexi-Q family in the disposable auto-injector category with similar customization and licensing models.
  • SHL Medical: Leading developer and manufacturer of advanced drug delivery systems including Molly, Maggie, and DAI auto-injectors. Directly competes with DALI's Flexi-Q family across disposable auto-injector formats serving biologic and biosimilar pharma partners.
  • Elcam Medical: Israeli medical device company and DALI's long-standing strategic partner through its E3D subsidiary. Both companies are direct peers in disposable auto-injector development, with Elcam owning/commercializing the Flexi-Q family that DALI invented.
  • Owen Mumford: UK-based manufacturer of auto-injectors (Aidaptus), safety syringes, and pre-filled syringe platforms for global pharma. Directly comparable to DALI's SAN safety needle and Flexi-Q auto-injector families targeting self-injection and life-cycle management use cases.

Broad incumbents

  • Gerresheimer AG: German specialty glass and plastics manufacturer producing syringes, auto-injectors, and drug delivery devices. Provides comparable prefilled syringe and auto-injector solutions to pharma customers, overlapping with DALI's Flexi-Q and SAN portfolios.
  • Stevanato Group: Italian drug containment and delivery solutions provider offering syringes, vials, and auto-injector platforms. Now encompasses the Haselmeier auto-injector business, directly competing with DALI's Flexi-Q family across disposable and reusable auto-injector formats.
  • West Pharmaceutical Services: Global leader in primary packaging and drug delivery devices including auto-injectors, prefilled syringes, and connected platforms (e.g., SmartDose). Directly comparable to DALI in serving pharma customers with injectable device platforms, but at significantly larger scale.
  • BD (Becton, Dickinson and Company): Global medical technology company with a substantial Pharmaceutical Systems segment offering prefilled syringes, auto-injectors, and safety systems. Broad incumbent competing with DALI across multiple product categories with greater scale and global reach.

Emerging players

  • Enable Injections: US-based developer of large-volume wearable injectors (enFuse) for subcutaneous delivery of high-volume biologics. Operates in an adjacent but expanding category that could compete with or complement DALI's Flexi-Q HV high-viscosity disposable platform.
  • Credence MedSystems: US-based developer of innovative injectable drug delivery systems including the Credence Connect auto-injector with companion app for adherence monitoring. Directly comparable to DALI's SYNNECT connected syringe strategy, with overlapping focus on connected/compliance-enhancing delivery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Dali Medical Devices social profiles

Digital presence

Dali Medical Devices compliance and trust

Trust signal

Compliance1 record

Dali Medical Devices financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Dali Medical Devices leadership team

Management profile

Number of profiles

Profiles6 records

Dali Medical Devices subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Dali Medical Devices funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Dali Medical Devices M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dali Medical Devices

What does Dali Medical Devices do?

DALI Medical Devices develops, manufactures, and licenses injectable drug delivery devices for pharmaceutical partners, including the SAN family of automatic safety needles, the SYNNECT connected IoT digital syringe, and the Flexi-Q family of disposable auto-injectors. The company provides end-to-end services from concept and design through verification, validation, regulatory support, and commercialization, offering both market-ready products and customized devices tailored to specific drug delivery requirements.

Is Dali Medical Devices a public or private company?

Dali Medical Devices is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Dali Medical Devices founded?

Dali Medical Devices was founded in 2003. It employs 11 to 50 people.

Where is Dali Medical Devices based?

Dali Medical Devices is headquartered in Yavne, Israel, in the Middle East region.

How does Dali Medical Devices make money?

Two revenue lines are on record. Device Manufacturing and Licensing is the primary driver. The others are custom Development Services.

Who are Dali Medical Devices's main competitors?

Direct peers on record are Ypsomed Holding AG, SHL Medical, Elcam Medical and Owen Mumford. Broad incumbents are Gerresheimer AG, Stevanato Group, West Pharmaceutical Services and BD (Becton, Dickinson and Company). Emerging players are Enable Injections and Credence MedSystems.

Does Dali Medical Devices have an API?

No public API is recorded for Dali Medical Devices.

What industry is Dali Medical Devices in?

Dali Medical Devices's product category is Drug Delivery Devices. Its primary akta.pro industry code is HLAHAIAB, Auto-Injectors (Disposable & Reusable), with a secondary code of HLAHAIAM, Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals